Casdin Partners FO1-MSV, LP
10% owner at GeneDx Holdings; Director at Standard BioTools.
- Rank
- 535th of 809
- Companies held
- 2
- Largest holding
- WGS, 98.4% of total
- Latest SEC filing
- May 28, 2024
- Listed but not counted
- $60.6M
What the $152M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| GeneDx Holdings WGS Class A Common Stock | Directly | 2,923,509 | $49.24 | $144M | 94.8% | Form 4, May 28, 2024 |
| GeneDx Holdings WGS Class A Common Stock | Indirectly (see filing footnote) Reported jointly by 3 insiders; split evenly | 111,048 | $49.24 | $5.5M | 3.6% | Form 4, May 23, 2024 |
| Standard BioTools LAB Common Stock | Indirectly (see filing footnote) Reported jointly by 2 insiders; split evenly | 3,774,000 | $0.61 | $2.3M | 1.5% | Form 4, May 23, 2024 |
| Standard BioTools LAB Common Stock | Directly | 103,556 | $0.61 | $64K | 0.0% | Form 4, May 23, 2024 |
Share counts are the amounts Casdin Partners FO1-MSV, LP reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Casdin Partners FO1-MSV, LP's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Standard BioTools LAB Common Stock | Through Casdin Partners Master Fund, L.P. Held by a company or fund the insider manages | 46,075,821 | $0.61 | $28.3M | — | Form 4, May 23, 2024 |
| GeneDx Holdings WGS Class A Common Stock | Through CMLS Holdings LLC Held by a company or fund the insider manages | 432,902 | $49.24 | $21.3M | — | Form 4, May 23, 2024 |
| Standard BioTools LAB Common Stock | Through Casdin Private Growth Equity Fund II, L.P. Held by a company or fund the insider manages | 13,939,637 | $0.61 | $8.6M | — | Form 4, May 23, 2024 |
| Standard BioTools LAB Common Stock | Through Casdin Partners FO1-MSV, LP Held by a company or fund the insider manages | 2,744,219 | $0.61 | $1.7M | — | Form 4, May 23, 2024 |
| Standard BioTools LAB Common Stock | Through CMLS Holdings II LLC Held by a company or fund the insider manages | 1,200,000 | $0.61 | $737K | — | Form 4, May 23, 2024 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 532 | Mpm Asset Management LLC 10% owner, Aktis Oncology | $153M |
| 533 | RC IV Cayman ICW Equity LLC Insider, Driven Brands Holdings | $152M |
| 534 | Honeywell International INC 10% owner, Quantinuum | $152M |
| 535 | Casdin Partners FO1-MSV, LP 10% owner, GeneDx Holdings | $152M |
| 536 | Third Rock Ventures VI, L.P. 10% owner, Rapport Therapeutics | $152M |
| 537 | General Catalyst Group VIII Supplemental, L.P. 10% owner, Samsara | $151M |
| 538 | Siddhi Sponsor LLC 10% owner, Siddhi Acquisition | $150M |
Other GeneDx Holdings insiders
All WGS insiders- Icahn School Of Medicine At Mount Sinai$134M10% owner. #1200 overall
- Jason Ryan$12.8MDirector. #7283 overall
- Katherine Stueland$5.7MCHIEF EXECUTIVE OFFICER. #13249 overall
- Emily M. Leproust$1.2MDirector. #1870 overall
Questions
How much stock does Casdin Partners FO1-MSV, LP own?
Casdin Partners FO1-MSV, LP holds $151,802,406 in listed stock based on SEC filings and current prices, mostly GeneDx Holdings (WGS). That ranks 535th on the Stock Rich List.
Is this Casdin Partners FO1-MSV, LP's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with SEC filer 1534264.